Safety and Efficacy of Reslizumab for Children and Adolescents With Eosinophilic Esophagitis Treated for 9 Years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of Reslizumab for Children and Adolescents With Eosinophilic Esophagitis Treated for 9 Years

Published:2018-06 Issue:6 Volume:66 Page:893-897
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Markowitz Jonathan E.,Jobe Laura,Miller Michelle,Frost Carrie,Laney Zegilor,Eke Ransome

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference20 articles.

1. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial;Spergel;J Allergy Clin Immunol,2012

2. Eosinophilic esophagitis: updated consensus recommendations for children and adults;Liacouras;J Allergy Clin Immunol,2011

3. Pathogenesis and clinical features of eosinophilic esophagitis;Rothenberg;J Allergy Clin Immunol,2001

4. Prevalence of eosinophilic esophagitis in the United States;Dellon;Clin Gastroenterol Hepatol,2014

5. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents;Markowitz;Am J Gastroenterol,2003

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of eosinophilic esophagitis in children: An update from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN);Journal of Pediatric Gastroenterology and Nutrition;2024-06-24

2. Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan;Drugs;2024-06

3. A Review of Non-IgE Immune-Mediated Allergic Disorders of the Gastrointestinal Tract;Gastrointestinal Disorders;2024-05-27

4. The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs;International Journal of Molecular Sciences;2024-01-30

5. Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case report;BMC Geriatrics;2024-01-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3